Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017

Kim, 2016, Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective, Clin Microbiol Rev, 29, 525, 10.1128/CMR.00058-15 Danino, 2018, Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children, Clin Infect Dis Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013; https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed August 12, 2019. Azarian, 2018, Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci, PLoS Pathog, 14, 10.1371/journal.ppat.1007438 Dagan, 2009, Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population, J Infect Diseases, 199, 776, 10.1086/597044 Fuhrmeister, 2019, The importance of antimicrobial resistance monitoring worldwide and the origins of SENTRY Antimicrobial Surveillance Program, Open Forum Infect Dis, 6, S1, 10.1093/ofid/ofy346 Mandell, 2007, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clin Infect Dis, 44, S27, 10.1086/511159 Prere, 2011, A specific polymerase chain reaction test for the identification of Streptococcus pneumoniae, Diagn Microbiol Infect Dis, 70, 45, 10.1016/j.diagmicrobio.2011.02.005 Mendes, 2015, Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States (2009-2012), Antimicrob Agents Chemother, 59, 5595, 10.1128/AAC.00182-15 2019, National center for biotechnology information, Basic Local Alignment Search Tool, 18 Kapatai, 2016, Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline, PeerJ, 4, e2477, 10.7717/peerj.2477 2014 Royston P.PTREND: stata module for trend analysis for proportions. 2014; https://econpapers.repec.org/software/bocbocode/s426101.htm. Accessed June 6, 2019. Hampton, 2012, Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines, J Infect Dis, 205, 401, 10.1093/infdis/jir755 Kaur, 2016, Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006-2015, Pediatr Infect Dis J, 35, 901, 10.1097/INF.0000000000001206 Tomczyk, 2016, Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine, Clin Infect Dis, 62, 1119, 10.1093/cid/ciw067 Lo, 2019, Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study, Lancet Infect Dis, 19, 759, 10.1016/S1473-3099(19)30297-X Isturiz, 2017, Streptococcus pneumoniae serotype 19A: worldwide epidemiology, Expert Rev Vaccines, 16, 1007, 10.1080/14760584.2017.1362339 Koutouzis, 2018, Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015, Vaccine, 36, 5245, 10.1016/j.vaccine.2018.07.055 Metcalf, 2016, Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States, Clin Microbiol Infect, 22, 10.1016/j.cmi.2016.08.001 Beall, 2011, Shifting genetic structure of invasive serotype 19A pneumococci in the United States, J Infect Dis, 203, 1360, 10.1093/infdis/jir052 Dagan, 2013, Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial, Clinical Infectious Diseases, 57, 952, 10.1093/cid/cit428 Bonten, 2015, Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults, N Engl J Med, 372, 1114, 10.1056/NEJMoa1408544 McLaughlin, 2018, Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: a test-negative design, Clin Infect Dis, 67, 1498 Gessner, 2019, A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands, Vaccine, 37, 4147, 10.1016/j.vaccine.2019.05.065 Rockett, 2018, Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia, Sci Rep, 8, 16969, 10.1038/s41598-018-35270-1 Melegaro, 2004, The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales, Eur J Epidemiol, 19, 365, 10.1023/B:EJEP.0000024752.48929.bd Diao, 2016, Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials, Vaccine, 34, 1496, 10.1016/j.vaccine.2016.02.023 Olarte, 2017, Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States, J Clin Microbiol, 55, 724, 10.1128/JCM.01778-16 O'Neill, 2016 Tin Tin Htar, 2019, The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review, Expert Rev Vaccines, 18, 1069, 10.1080/14760584.2019.1676155 Pillai, 2009, Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae, BMC Genomics, 10, 642, 10.1186/1471-2164-10-642 Naucler, 2017, Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations, Clin Infect Dis, 65, 1780, 10.1093/cid/cix685